Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
ExpreS2ion Biotech Holding AB banner
E

ExpreS2ion Biotech Holding AB
F:5JD0

Watchlist Manager
ExpreS2ion Biotech Holding AB
F:5JD0
Watchlist
Price: 0.0988 EUR -2.18% Market Closed
Market Cap: €348.8k
Write Note Create Alert Ask AI

Wall St Price Targets

5JD0 Price Targets Summary
ExpreS2ion Biotech Holding AB

Wall Street analysts forecast 5JD0 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 5JD0 is 0.4366 EUR with a low forecast of 0.4323 EUR and a high forecast of 0.4494 EUR.

5JD0 Lowest Forecast
Wall Street Target
€0.4323
338% Upside
5JD0 Average Forecast
Wall Street Target
€0.4366
342% Upside
5JD0 Highest Forecast
Wall Street Target
€0.4494
355% Upside
Lowest Forecast
Price Target
0.4323 EUR
338% Upside
Average Forecast
Price Target
0.4366 EUR
342% Upside
Highest Forecast
Price Target
0.4494 EUR
355% Upside
ExpreS2ion Biotech Holding AB Competitors:
Price Targets
D
DSS
Dss Inc
462% Upside
RLMD
Relmada Therapeutics Inc
161% Upside
NNOX
Nano-X Imaging Ltd
629% Upside
D
DSS
Dss Inc
462% Upside
RLMD
Relmada Therapeutics Inc
161% Upside
NNOX
Nano-X Imaging Ltd
629% Upside

Revenue
Forecast

N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
39% / Year
Estimated Growth
Estimates Accuracy
3%
Average Beat

The compound annual growth rate for Revenue over the next 3 years is 39%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for ExpreS2ion Biotech Holding AB

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

What are analyst estimates?

Continue 5JD0 Research

Summary
5JD0 intrinsic value, competitors valuation, and company profile.
DCF Valuation
5JD0 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
5JD0 stock valuation using valuation multiples.
Wall St Estimates
5JD0 price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
5JD0 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other ExpreS2ion Biotech Holding AB listings:
F • EUR
5JD
 STO • SEK
EXPRS2
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 5JD0's stock price target?
Price Target
0.4366 EUR

According to Wall Street analysts, the average 1-year price target for 5JD0 is 0.4366 EUR with a low forecast of 0.4323 EUR and a high forecast of 0.4494 EUR.

What is the Revenue forecast for ExpreS2ion Biotech Holding AB?
Projected CAGR
39%

The compound annual growth rate for Revenue over the next 3 years is 39%.

Back to Top
ALPHA SPREAD
Follow us
Join 350,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett